(NASDAQ: QDEL) Quidelortho's forecast annual revenue growth rate of 3.92% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 10.12%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 15.01%.
Quidelortho's revenue in 2026 is $2,730,200,000.On average, 10 Wall Street analysts forecast QDEL's revenue for 2026 to be $192,603,318,843, with the lowest QDEL revenue forecast at $183,888,852,667, and the highest QDEL revenue forecast at $198,866,841,407. On average, 9 Wall Street analysts forecast QDEL's revenue for 2027 to be $200,432,722,048, with the lowest QDEL revenue forecast at $191,854,419,406, and the highest QDEL revenue forecast at $207,036,653,447.
In 2028, QDEL is forecast to generate $209,215,269,991 in revenue, with the lowest revenue forecast at $199,888,067,912 and the highest revenue forecast at $216,023,446,691.